Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy - Wikidata - awgldk - TriplyDB

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

http://www.wikidata.org/entity/Q37140126

about

Stem cells as cellular vehicles for gene therapy against glioblastoma Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Immunotherapeutic organoids: a new approach to cancer treatment Mesenchymal stem cells as delivery vectors for anti-tumor therapy Assessment of stem cell carriers for tendon tissue engineering in pre-clinical models In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals Mesenchymal stem cell secretome and regenerative therapy after cancer Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma.Genetically modified mesenchymal stromal cells in cancer therapy Cell or cell membrane-based drug delivery systems Practical Issues with the Use of Stem Cells for Cancer Gene Therapy Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma Pharmacokinetics of natural and engineered secreted factors delivered by mesenchymal stromal cells Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation.Pre-exposure of human adipose mesenchymal stem cells to soluble factors enhances their homing to brain cancer.Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma.Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells.Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors.Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact.Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.AAV-iRFP labelling of human mesenchymal stem cells for near-infrared fluorescence imaging Systemically Infused Mesenchymal Stem Cells Show Different Homing Profiles in Healthy and Tumor Mouse Models Mesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survival TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors Construction of Various γ34.5 Deleted Fluorescent-Expressing Oncolytic herpes Simplex type 1 (oHSV) for Generation and Isolation of HSV-Based Vectors Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface.Advances in mesenchymal stem cell-mediated gene therapy for cancer.Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.Proteome changes during bone mesenchymal stem cell differentiation into photoreceptor-like cells in vitro.Current status of gene therapy for brain tumors.A first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapy Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery Engineering toxin-resistant therapeutic stem cells to treat brain tumors Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrine-like mechanisms

P2860

Q26771835-998D8690-562B-4DF3-8F96-BE589A178356 Q26799013-132E8E7A-025D-4DA1-AD68-BF866BA05364 Q26830028-D5336318-C5A6-4C43-8653-B7565FF5180B Q26853431-A55237E4-5753-4EDF-9152-6374451D8A7A Q26861201-08ECF82A-79E0-4336-80D6-7C680241E50F Q26865339-2BC4F4B8-5450-460A-9F6C-0BF97601592E Q27006069-EAF81208-D38A-4EB6-B6DF-68F82ECF2D4F Q27007499-4989A47A-4E18-409D-844C-8400D018AA71 Q27333831-B8FA064D-BEE1-4FC9-8257-02FC514EE0D5 Q28071840-B0A1948D-F597-4A29-A1F5-7FB121C8F9A9 Q28080710-3F59C049-738E-440C-A096-BC8188F76D7F Q28085238-6B898FA3-BA61-446A-95EC-2816106E20CC Q28473229-73632707-4204-45AE-BC0E-680372C14159 Q28540077-BA2B28C8-AFA6-4B71-843B-C7420CED1ED8 Q29620590-E65758C3-52F1-4729-A30A-008F7738CED9 Q30548207-89019F43-563C-48BD-8B55-8E013CA2FA77 Q30621190-D8C03A5F-0E0F-4CE8-A94C-BDD9CDB4CD1C Q30843565-41BB6420-1BA9-4541-95C9-68BFFF991713 Q30854013-94191448-B1E2-47B1-BB9F-C846FFF3C0DD Q33560685-7BF65C1E-AD5B-463F-BB78-39C235226A34 Q33595542-AD8DE77B-9626-4F81-AE48-16190E67439F Q33609232-993EEA15-FF23-490D-BC56-4CDE08851EFB Q33613433-280315A6-2D94-498D-AA81-9F4E502C04B1 Q33722638-763712AD-28CD-4ED4-A036-771C25942FDB Q33728678-01CB53C6-DAFC-4213-BCB1-D3ACE4181367 Q33743051-D6D6B93A-501B-4F32-B72F-6CEA334B0FA6 Q33753135-CC23ACAD-9B99-4612-AC0C-85C644C31326 Q33766379-3072E665-3EBF-4663-8E2E-CE639A0DAC31 Q33834736-C2EEE629-927E-440D-BF4C-C13E97AB03F8 Q33892058-06CFAFDF-9361-40A1-806D-48296AE5BDAC Q34135233-25DA907A-6135-4A24-AAC7-2AA1F9DD78B5 Q34240433-A0D52407-8D13-4622-936A-F5DF8302F151 Q34254612-EB8977C6-B4FD-4A55-B21B-07585523C405 Q34318157-A13188DC-8C5D-4E66-82A5-1C301A3C5E53 Q34341900-95AFBCAA-FB5F-47A5-BC78-3D6BBBEBBE25 Q34349428-4CC0A6DB-2B22-4D8C-AE19-DBFAC28B9264 Q34444939-98CA7902-7C4E-49F2-91DB-89984ACDFACF Q34474267-7A162FCD-6D47-4154-8464-5B810DC75148 Q34534990-FD09486D-B717-4578-9627-54FFE22E13AA Q34596348-BD4D4202-CEFD-41EE-8D7C-BB207740A64F

P2860

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

http://www.wikidata.org/entity/Q37140126

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Assessment of therapeutic effi ...... stem cells for cancer therapy

@en

Assessment of therapeutic effi ...... stem cells for cancer therapy.

@nl

type

label

Assessment of therapeutic effi ...... stem cells for cancer therapy

@en

Assessment of therapeutic effi ...... stem cells for cancer therapy.

@nl

prefLabel

Assessment of therapeutic effi ...... stem cells for cancer therapy

@en

Assessment of therapeutic effi ...... stem cells for cancer therapy.

@nl

P1433

Q37140126-B6EFCBDA-7479-4F62-A984-9A8062F79C31

P1476

Q37140126-06ACC6FF-2148-4B21-81FF-CE74E1F54E23

P2093

Q37140126-4BF26D15-0904-4392-A080-307C20D67594

Q37140126-4ED2BD92-0293-4C82-872A-3DADC6A81181

Q37140126-6D3D121F-A29F-44C5-8A3E-6F318DC8794B

Q37140126-9F96E309-66F9-4B86-AD7A-07AEB3D419F0

Q37140126-AA71DD29-A7A7-4ACA-B09E-9CBC0DCFBEBF

Q37140126-DB2FBD91-3035-4BD2-A763-3712593743CD

Q37140126-FCBAFDCE-789A-4166-B524-A370EE80EA98

P2860

Q37140126-0329BE6B-751E-4E98-95DB-3DE8DF1580EA

Q37140126-0B725E31-6392-4DB9-AFD0-D9E0B772CF94

Q37140126-0BA3B8D3-6828-4282-ADD0-E858668EB961

Q37140126-0F5497AB-11AA-4171-A467-8FE8289167B5

Q37140126-107D9B96-A6F4-41F8-A740-32D82BEFE723

Q37140126-18A350F1-DA35-4F9D-A10C-09161BB79489

Q37140126-1F139068-7175-424A-A802-269C54C00227

Q37140126-21C285B8-1778-40B9-8E78-3C0FF9BCD551

Q37140126-25A53C53-240F-4803-98A1-9C76C644E1C5

Q37140126-2A6F6AF9-F982-4273-8278-C89134719965

P304

Q37140126-B653896B-7253-4F41-A65B-A1E4B89A2BAF

P31

Q37140126-435E5A88-A58D-45D5-B4C6-D11C1ED8FFF1

P356

Q37140126-C41F2D52-341C-4619-90F5-F6844D7EFC5D

P407

Q37140126-A9886327-7C8E-4D93-BE6B-A3CF8C8F6E79

P433

Q37140126-6D32053F-A6F3-476D-9BC3-F3BBD74765BE

P478

Q37140126-459BA17E-58B7-4FC2-A836-D0BFAC2D1CD7

P50

Q37140126-0D56A91C-D58C-4B0A-B8F7-86D5D4EC2E75

Q37140126-C00A38EB-CF47-4EEE-A3C3-AB7B229DC9C7

Q37140126-C12CB05B-5EC0-4633-BF10-628797B7D560

P577

Q37140126-E0AF7E78-C1C5-4FCD-9BE9-D140A43F6AB9

P5875

Q37140126-238FF655-6F0C-4519-B1B9-83D8A424CBF9

P698

Q37140126-5F0C5452-8F2B-4B4F-9B11-1C0ED24EDF58

P932

Q37140126-0EB4CAC6-A757-489D-964C-8F6F46D1B3AA

P356

PNAS.0806647106

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Assessment of therapeutic effi ...... stem cells for cancer therapy

@en

P2093

Gayatry Mohapatra

http://www.w3.org/2001/XMLSchema#string

Hiroaki Wakimoto

http://www.w3.org/2001/XMLSchema#string

Jose Luiz Figueiredo

http://www.w3.org/2001/XMLSchema#string

Khalid Shah

http://www.w3.org/2001/XMLSchema#string

Laura S Sasportas

http://www.w3.org/2001/XMLSchema#string

Randa Kasmieh

http://www.w3.org/2001/XMLSchema#string

Shawn Hingtgen

http://www.w3.org/2001/XMLSchema#string

P2860

Human adult CD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4

Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway

Identification of human brain tumour initiating cells

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

A perivascular niche for brain tumor stem cells

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

Pluripotency of mesenchymal stem cells derived from adult marrow

MCP-1 induces migration of adult neural stem cells.

mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells

Apoptosis in human glioblastoma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand.

P304

4822-4827

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0806647106

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Jeroen van de Water

Robert L Martuza

P577

2009-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24180810

http://www.w3.org/2001/XMLSchema#string

P698

19264968

http://www.w3.org/2001/XMLSchema#string

P932

2660771

http://www.w3.org/2001/XMLSchema#string